As per an article in The Australian on 14th Dec, Healthscope could be a takeover target by listed real estate group — either Dexus or Charter Hall jointly with another healthcare operator. It was pitched to parties by investment banks.
HSO Price at posting:
$2.04 Sentiment: Buy Disclosure: Held
